Cure Childhood Cancer

CURE Blog


November 23rd, 2010

Atlanta Thrashers’ Forward Jim Slater Chooses CURE to Receive Proceeds of Special Award

The Atlanta Thrashers foundation recently donated $5,000 to CURE Childhood Cancer on behalf of Thrasher forward Jim Slater. In a special on-ice ceremony at the Atlanta Thrashers regular-season finale, Slater was honored as this year’s recipient of the Dan Snyder Memorial Trophy, named after former Thrasher Dan Snyder, who was tragically killed in a car accident in 2003. The trophy was presented to Slater by members of the Snyder family and is annually bestowed to the player who best embodies perseverance, dedication and hard work, and does so quietly, without fanfare or reward.

“The Thrashers have shown longtime support for CURE and a determination to make a difference in the lives of children stricken with cancer,” says Kristin Connor, CURE’s Executive Director.

In addition to this year’s donation to CURE Childhood Cancer on Slater’s behalf, the Thrashers foundation has been a generous supporter of CURE for many years, providing grants in years past to support the organization’s Open Arms Program. The Thrashers have also hosted children with cancer at Thrashers’ games and other events where they have unique opportunities to personally interact with the players. “The light in our kids’ eyes when they meet a Thrashers’ player or get to attend a game shines so bright,” Connor says, “and that is truly priceless.”

“CURE Childhood Cancer is a tremendous organization which we have worked with on numerous community outreach projects,” says Thrashers President Don Waddell. “On behalf of Jim Slater, and in honor of his achievement as the 2010 Dan Snyder Memorial Trophy winner, it is a privilege to award CURE with this Atlanta Thrashers foundation grant.”


November 22nd, 2010

A Day of Grace : Remembering a Special Little Girl and Fighting Back

On June 5, 2010, Lynne and Steven Bell remembered their daughter in a special way. Grace Morgan Bell was born June 6, 2002 and diagnosed with leukemia September 30 that same year. She died on January 1, 2006.

Tragedy plagued the Bells as their second child, Hudson Isaac Bell, was born on September 23, 2005 and died six days later from fanconi’s anemia, a rare genetic disorder. “Our ‘Day of Grace’ is in celebration of our daughter’s birthday,” said lynne Bell. “It’s going to be her eighth birthday this year. Every year since she passed away, we’ve tried to honor and celebrate her life by doing something special around her birthday. This year, we wanted to do something special for her again, to come up with an idea to try to help other kids with cancer, and their families.”

The event in locust Grove had a “Wings of Grace” yard sale, games, a bake sale, a silent auction, food and a special balloon release. “A Day of Grace” raised an astounding $3,000 for CURE Childhood Cancer. But for everyone involved, the day was about much more than the money raised. The activities during “A Day of Grace” also provided a healing experience for Steven and lynne and the many family and friends who came out to remember Grace and support the Bells.

“One thing that makes it special for me, so many people don’t know what to do with you after you’ve lost a child. They don’t know if they can talk about your child,” Steven said. “I think it gives them an opening to say, ‘oh yeah, they do want us to talk about their child.’ You do, just as much as you want to talk about your kids who are still here. A lot of times people avoid that topic.”

Steven said he has a message for others facing a situation similar to what he and his wife went through. “You can make it. We have friends who just lost a child, and I stood there with them the other night and said, ‘You can make it, I just want you to know.’


November 19th, 2010

Survivorship 101: Care After Cancer

Childhood cancer treatment is tough. oncologists use a combination of chemotherapy, radiation, surgery and hematopoietic stem cell transplant all with one primary goal: cure. fortunately research in pediatric oncology treatment over the past few decades has been incredibly successful. The overall cure rate for pediatric cancer is currently close to eighty percent (80%). Most children diagnosed with cancer today will become long-term survivors.

As healthcare providers we realize our commitment to the health of these patients doesn’t end at cure. Maybe you’ve heard the word ‘late effect’ or read information about health problems after cancer treatment. The treatments used to defeat childhood cancers can damage normal tissues and cause health problems after therapy; these are called ‘late effects’.

Research in the field of survivorship has shown that many survivors develop a health problem after cancer treatment. In an article published in the New England Journal of Medicine, looking at health conditions in a study of 14,000 adult survivors of childhood cancer, oeffinger et al. found that 66% of the adult survivors had at least one chronic health condition, many of which were late effects of cancer therapy. fortunately most of these conditions are not severe. Childhood cancer survivors are at risk for medical, psychological, and social problems after completing treatment (you can see a list of late effects in Table 1). Risk for these problems is influenced by many factors, most importantly: diagnosis, cancer therapy regimens and age at treatment.

As survivors move farther away from treatment, the risk of cancer recurrence decreases, but the risk for late effects is still present and in some cases increases with time, which is why life-long monitoring is crucial for survivors. Some late effects like thyroid disease, cardiac disease or infertility are not diagnosed until a decade off therapy. As patients and families transition back to a life without cancer treatment, it can be worrisome to think about potential health problems that may occur as a result of their cancer therapy. The impact of late effects on a survivor’s quality of life can be minimized through early detection and intervention. Early detection can be achieved through regular screening using evidence-based monitoring guidelines. The best way for patients to maintain health is to have regular survivor focused healthcare check-ups. Survivors should be seen regularly in a Survivor Clinic or long-Term follow-Up clinic.

Risk for late effects is dependent on the survivor’s cancer treatment so an accurate summary of treatment is necessary to determine an individual’s risk for late effects. During a childhood cancer survivor clinic visit, survivors (and their families) are educated about the specific late effects for which they are at risk, and how to screen for these health problems. The survivor team will create a Survivor Healthcare Plan, or SHP, that will include 3 things: 1) a summary of the patient’s cancer diagnosis and treatment, 2) an individualized risk profile and 3) a surveillance plan listing which tests should be done to diagnose the specific late effects for which the patient is at risk. This surveillance plan becomes the “roadmap to survivor care.”

The long-term follow-Up Guidelines for Survivors of Childhood, Adolescent, and Young Adult Cancers (www.survivorshipguidelines.org), created and maintained by the Children’s oncology Group, are used to develop the risk profile and appropriate surveillance plan for the patient. With the advances in pediatric cancer treatment leading to high survival rates, it is crucial to provide survivors with the specialized healthcare they need to lead long, successful and productive lives. The Aflac Cancer Survivor Program is committed to keeping survivors healthy, learning more about late effects of childhood cancer through survivor focused research and partnering with other healthcare providers to provide optimal care to survivors. In Georgia there is a network of healthcare providers who are working together to ensure that every childhood cancer survivor in the state of Georgia has access to the appropriate long-term follow-up care and CURE is a part of this effort.

To find a cancer survivor clinic contact the hospital where you received cancer treatment. To learn more about childhood cancer survivorship visit www.survivorshipguidelines.org and www.cancersurvivorlink.org.


November 18th, 2010

Funding Fellowships : Why We Do It

CURE Childhood Cancer has made it a top priority to dedicate more than a million dollars each year to support ground-breaking pediatric cancer research. As part of that support, CURE fully funds two pediatric oncology fellows at Emory University School of Medicine.

“Although cancer kills more children than any other disease, when compared to cancer stricken adults, the numbers of children diagnosed each year are often deemed by the federal government and pharmaceutical industry to insignificant to invest significantly in research for cures,” says Kristin Connor, CURE’s Executive Director. “We don’t think children should be lumped in with adult cancer patients but should be considered a critically important segment of our population. As a nation, we should care what diseases affect children and we should invest in finding the best treatments and cures for those diseases.”

Dr. Michael Briones couldn’t agree more. Dr. Briones is an Associate Professor at Emory University School of Medicine and has recently been appointed to head the fellowship program. His primary responsibility in his position is to continue to attract the best and the brightest academic scientists who will continue the process to ultimately discover innovative treatments and cures for pediatric cancer.

A fellow is an M.D. who has completed residency training in general pediatrics and is currently an academic scientist in a three-year subspecialty training program in pediatric hematology/oncology. Upon completion of the fellowship program, these physicians become highly specialized pediatric oncologists. over the years, CURE has funded a total of eleven fellows.

With only 60 accredited pediatric hematology/ oncology fellowship programs in existence nationwide, the fellow selection process is fiercely competitive. According to Dr. Briones, he receives an estimated 40-60 applications annually. He interviews the top 20 candidates but only four are selected per year for a total of 12 slots program-wide. “We have a preeminent mentorship program for our fellows that rivals the best in the country. The only way to move research in the hope of finding a cure for childhood cancer is to train fellows in excellent labs, and we have those labs here. People tend to want to fund specific projects but I think funding the mind of a researcher in training is just as important, if not more so, because that’s how projects get developed. our goal is that one of our fellows will eventually find a cure for cancer. For the past few years we‘ve been able to secure a top rank of fellows in our program. CURE is helping us to attract the cream of the crop,” Dr. Briones explains.

Throughout their first year, fellows dedicate their time to clinical rotations which allows them to be directly involved with inpatient hematology/ oncology, neuro-oncology, laboratory rotation and research exploration. The second and third years of fellowship training include an emphasis in specific areas of research where they choose to be clinical research investigators or basic science researchers. Three years of funding are guaranteed.

A fourth year is offered but no secure funding is provided so Dr. Briones is constantly scrambling for funding opportunities to protect and further those fellows involved in a critical stage of their research. Completion of the fourth year also makes fellows much more marketable when they start competing for the highly anticipated external grants, like NIH R1 or K Grants. “Impressively, some of the fellows funded by CURE have continued their work at other top institutions. Some of our top cancer researchers wouldn’t be where they are today, on the cusp of developing cancer therapies and finding cures for specific pediatric cancer, without CURE’s financial support,” according to Dr. Briones.

There are several areas where CURE’s funded fellows are close to groundbreaking outcomes, particularly in innovative therapeutics and Phase 1 trials, an area which has grown dramatically. “The research we are conducting here at Emory in innovative gene therapy is dramatic. CURE funds some of that too, which is very exciting, as it postures us to host clinical trials here. That’s another reason CURE’s support of our fellows is so vital. It’s incumbent upon us to continue funding researchers who can come up with new therapies. Part of my job is to ensure that we have the research capability and curriculum in place, and viable sources to fund all of our fellows,” Dr. Briones explains.

According to Connor, “of the eleven fellows CURE has funded, every one of them is now a leading pediatric oncologist. Some of these doctors have continued at Children’s Healthcare of Atlanta and some have gone on to join the staffs of other top pediatric cancer hospitals all over the country. ” She adds, “Through these doctors, CURE continues to touch the lives of countless children with cancer in communities nationwide, and for that, we are exceptionally gratified to all of whom contribute to CURE.”

“We must continue to attract top minds through dedicated and committed donors like CURE,” states Dr. Briones. “It’s the only way to help us achieve the ultimate measure of success which is the discovery of a cure for children’s cancer,” he notes. ”


November 16th, 2010

Sean Michael Dever

If you are anything like me you go through life preparing for the bumps in the road which might pop up unexpectedly. You go through life preparing for obstacles that might appear before you. You go through life preparing for your family’s future by purchasing life, health, auto and home insurance just in case. But how do you prepare for the unimaginable? How do you prepare for a doctor to tell you your child has cancer? How do you prepare your little boy for the loss of his leg? How do you prepare your 11-year-old for the possibility he may never step foot on a basketball court again? How… ?

This is exactly what we had to do in July 2007, when our youngest son, Sean, was diagnosed with osteosarcoma, a bone cancer, in his left knee. Sean had been complaining about a sore knee but initial x-rays did not show anything alarming. After a month of pain, sleepless nights and a progressive limp, we finally insisted on an MRI. Thus began our journey, and it is a lifetime journey, into pediatric oncology.

If you are reading this newsletter published by CURE, you probably have been touched in some way by pediatric cancer. The first time I picked up this publication, I was sitting in the Aflac Cancer Center on the fourth floor numb, looking around at all the children and their parents thinking, “I cannot believe I am here. How did we end up here? I am not strong enough for this.” That was two days after Sean’s diagnosis, as my husband, John, Sean and I sat in the waiting room for our first appointment with Dr. Bradley George. I looked at all the children and wondered, “What is your life like?

How are your parents dealing with siblings, jobs, everyday activities, school?” I thought I would find the answers on their faces because I needed to find the answers somewhere. But I didn’t find answers that day from strangers; I found my answers through my 11-year-old son. Sean sat in every meeting with us while words like osteosarcoma, chemotherapy, amputation, rotationplasty, doxorubicon, cisplatin, and methotrexate were uttered. Words we would all come to know like our own names. Sean gave me more strength, showed me more character, and bestowed more grace than anyone I had ever known. I am so proud to say I am Sean’s mom.

By the weekend, our community was aware of Sean’s cancer. Sean was the fourth child to be diagnosed with cancer at his school in five years, so we were surrounded by love, compassion and people who had walked this walk. That weekend, Sean made a phone call to his friend Andrew Vassil, who had been diagnosed at six years old with an inoperable brain tumor. Sean and Andrew, two 11-year olds, had a conversation about cancer and biopsies, not sports and girls mind you – cancer and biopsies! How surreal is that?

While the initial diagnosis of cancer was devastating, the surgical options presented to us were just as overwhelming. Not only did my little boy have cancer and have to go through 30 rounds of chemotherapy, but they would have to take his leg, too! I was in shock…he’s got things to do, games to play…please, please, no.

After a month of research, consultation, and prayer it was decided that the best chance for Sean to live a cancer-free life and continue the life God intended was to undergo rotationplasty surgery. Complete amputation and limb-salvage were also presented as options but the surgeon told us rotationplasty would give Sean the most function and usually only means one surgery. More function, less time in the hospital – sign us up!

Sean’s left knee and most of his thigh were removed (and the cancer!) in october 2007, his lower leg was rotated 180 degrees and reattached to the remaining part of his thigh. for those who have never heard of rotationplasty, and I know it is hard to imagine, Sean’s heel is now his new knee while his foot acts as a regulator for his prosthesis.

It has been almost three years since Sean’s diagnosis, and while this may sound odd, childhood cancer has made us better people. When applying to college last year, my daughter wrote about her brother’s fight, “Having something so bad happen to your family weirdly has amazing outcomes.” I couldn’t agree more.

Our family has been involved in many fundraisers for childhood cancer through CURE. finding a cure has given me a purpose in life I never would have found if not for Sean’s diagnosis. I have sat with senators educating them about the lack of funding for pediatric cancer, asking them for their help. I have even spoken in front of more than a thousand people telling them about children with cancer, asking them for money – this was way out of my comfort zone for sure, but I will do anything for these kids.

Today, Sean is cancer-free. We go in for chest x-rays every four months. He is on his fifth prosthetic – he just keeps growing! He will be attending Blessed Trinity Catholic High School in August. He plays football, basketball and this summer he has been selected to play in an elite travel lacrosse league. My boy is living the life God intended and we are more than blessed to sit on the sidelines and cheer him on.


November 15th, 2010

New Target Could Lead to New Treatments for Childhood Cancer

It’s not uncommon for police detectives to link a convicted criminal to other crimes. The bad guy often turns out to be more villainous than first thought.

Two CURE funded researchers at the Aflac Cancer Center and Blood Disorders Service of Children’s Healthcare of Atlanta have linked an already-known genetic bad guy to another crime, in a manner of speaking. By finding that link, Dr. Muxiang Zhou and Dr. Lubing Gu have found a new target in cancer cells. Finding a way to attack that new target could lead to improved treatments for children with leukemia and other cancers.

A gene called TP53 (typically referred to as p53) plays a well-known role in the body’s fight against cancer. Mutations of the p53 gene hobble that cancer-fighting ability of cells. That mutation is found in about half of adult cancer patients.

High levels of a protein called MDM2, encoded by the murine double minute (MDM2) gene, inhibit the ability of p53 to suppress the growth of cancer cells, says Zhou.

As a result, even in patients with normal p53 genes that is found in over 90% pediatric cancers, a high level of MDM2 means “the disease progresses very fast and is resistant to drugs and radiation,” Zhou says.

Research by Zhou and Gu, published earlier this year in the prestigious medical journal Cancer Cell, revealed that not only does MDM2 inhibit the cancer-fighting p53, it boosts production of XIAP, a protein that protects cancer cells, making them resistant to treatment.  Zhou and Gu have received generous grants from CURE Childhood Cancer to support this research.

This discovery is totally unexpected and is what most call target discovery.  Researchers find a target, and then must find something to do about it.

Gu and Zhou are now hunting for a compound that will break the connection between the MDM2 and XIAP molecules. Think of wrapping black electrical tape around the ends of two wires.

“Inhibition of the interaction between MDM2 and XIAP with small molecules can allow cancer cells to become more sensitive to chemotherapy,” says Gu.

The researchers tested 1,280 FDA-approved drugs in the first phase of laboratory study and found just four that have the potential to treat cancer patients. One of those four drugs – a compound known as MX3 – strongly inhibited production of XIAP in cancer cells with high levels of MDM2.

“This suggests that MX3 could be the best candidate to be developed as a potential new drug,” says Gu, an assistant professor of Pediatrics at Emory University School of Medicine.

A second wave of testing using 2,000 natural products identified a dozen more that may have potential as therapeutic drugs. Continuing research being done in cooperation with Dr. Haian Fu, a professor of pharmacology and the director of the Chemical Biology Discovery Center at Emory University School of Medicine will test the effect of roughly 38,000 chemical compounds on the MDM2-XIAP connection.

Drug testing is expected to move from test tubes to a test subject this year.

“CURE is proud to be a long time supporter of Dr. Zhou’s and Dr. Gu’s promising research,” remarks Executive Director Kristin Connor.  “We are very concerned with making new treatments available to children as quickly as possible. We are pleased that Drs. Zhou and Gu share our urgent concerns.”


November 9th, 2010

Equifax Partners with Local Atlanta Chefs to Sponsor Open Arms Today

Today’s sponsor for our Open Arms meals at the Egleston and Scottish Rite campus locations is local partner, Equifax. They have taken a fun approach to providing today’s meals by partnering with a number of local Atlanta chefs to prepare boxed lunches for the families! Equifax employees will volunteer their time today to help distributed the lunches to the families.

Here is a list of some of the folks that are involved with providing today’s food:

· UCCA
· East Lake Golf Club – Chef Michael Deihl
· Sysco Foodservice
· Imperial Fez – Chef Rafih Benjelloun
· LMSC, Inc – Chef Curtis H. Hicks, Jr.
· Hospitality Education Foundation of GA (HEFG) – Lee Gray
· Dietz & Watson – Brian Froman
· Kellogg’s – Leslie Fight
· Phoenix Wholesale – Roy Collins
· Tropical Fruit & Nut – Hal Saxby
· Blue Frog Foods – Chef David Reid
· City Café & Bakery – Chef Jorge Schatte
· Equifax

We are so thankful for companies like Equifax who volunteer & sponsor CURE Childhood Cancer and our Open Arms Program – so many thanks to you all!


November 5th, 2010

CURE Childhood Cancer offices have moved!

CURE Childhood Cancer has moved! As of November 5, 2010, our office will be located at:

1117 Perimeter Center West
Suite N402
Atlanta, GA 30338

Our phone and fax numbers will remain the same:

770.986.0035 (office)
770.986.0038 (fax)

Please update your records!


November 3rd, 2010

Whimsical Wares supports CURE Childhood Cancer

Whimsical Wares is an annual art & gifts show in it’s 14th year featuring over 90 artists, and this year a portion of the proceeds from the event will benefit CURE Childhood Cancer. This year’s event will be held November 10-14, 2010 in Marietta, GA.

Started by friends Debbie and Helaine, the two were delighted to find that they had many things in common – including a love for art, design and the unique.

Featuring everything from photography to jewelry, wood & clay, to handbags & home accents – the selection of gifts is both unique & extensive. Come out and join us, and support CURE Childhood Cancer at the same time!

Click here for directions, times & location.


  •  

    Screen Shot 2013-05-06 at 4.25.29 PM

    Nacho Average Taco

    For May and June, order the CURE taco at Red Pepper Taqueria and $1 will be donated to CURE. The taco features chargrilled calamari, crispy eggplant, tomato, onion, sorrel, and ginger pico.


  • Screen Shot 2013-05-14 at 2.49.59 PM

    Home by Dark - Singer/Songwriter Show

    Saturday June 1st at 8PM at Chukkar Farm in Alpharetta, GA. A portion of the proceeds will benefit CURE. Bring your own chairs and picnic for this beautiful outdoor music event. Click here to learn more.